If You Have Cancer & Have Used Depo-Provera, You May be Entitled to Significant Compensation.

See If You Qualify for Compensation Now!

• A March 2024 study linked long-term use of Depo-Provera to an increased risk of meningioma in over 108,000 women.
• The study found an odds ratio of 5.5, indicating users of Depo-Provera are more than five times more likely to develop Meningioma.

Federal Lawsuit Filed Against Pfizer for Depo-Provera-Related Brain Tumor

A California woman, Kristina Schmidt, has filed a federal lawsuit against Pfizer after using Depo-Provera for 17 years and subsequently developing an intracranial meningioma at age 37. Her attorneys argue that Pfizer neglected to update the drug’s label to warn about the association between progesterone-based contraceptives and brain tumors, despite evidence linking the medication to such risks.

Alarming Tumor Risk Linked to Depo-Provera Exposed in Groundbreaking Study

A March 2024 study published in the British Medical Journal linked long-term use of Depo-Provera to a significantly increased risk of brain tumors, specifically meningiomas, with users being more than five times as likely to develop them after a year of use. Although Pfizer acknowledged the findings and promised to update product labels, as of October 14, their online resources still lack information on these risks. Previous studies in 2022 and 2023 have also pointed to similar concerns. If you or a loved one has been diagnosed with a meningioma following prolonged use of Depo-Provera, you may have grounds for a lawsuit; The Lanier Law Firm is available to discuss potential legal actions.